Antipsychotic-induced akathisia in adults with acute schizophrenia: A systematic review and dose-response meta-analysis.
Wu H, Siafis S, Wang D, Burschinski A, Schneider-Thoma J, Priller J, Davis JM, Leucht S.
Eur Neuropsychopharmacol. 2023 Jul;72:40-49. doi: 10.1016/j.euroneuro.2023.03.015. Epub 2023 Apr 17.
[Drug-induced akathisia].
van Harten PN.
Ned Tijdschr Geneeskd. 2002 Jan 19;146(3):110-4.
Akathisia and Restless Legs Syndrome: Solving the Dopaminergic Paradox.
Ferré S, Guitart X, Quiroz C, Rea W, García-Malo C, Garcia-Borreguero D, Allen RP, Earley CJ.
Sleep Med Clin. 2021 Jun;16(2):249-267. doi: 10.1016/j.jsmc.2021.02.012. Epub 2021 Apr 10.
[Akathisia--diagnosis, pathophysiology and therapy].
Zyss T, Banach M, Zieba A.
Psychiatr Pol. 2009 Jul-Aug;43(4):387-402.
Akathisia and second-generation antipsychotic drugs.
Kumar R, Sachdev PS.
Curr Opin Psychiatry. 2009 May;22(3):293-99. doi: 10.1097/yco.0b013e32832a16da.
Treatment of Antipsychotic-Induced Akathisia: Role of Serotonin 5-HT(2a) Receptor Antagonists.
Poyurovsky M, Weizman A.
Drugs. 2020 Jun;80(9):871-882. doi: 10.1007/s40265-020-01312-0.
Drug-induced akathisia: a review.
Ball R.
J R Soc Med. 1985 Sep;78(9):748-52. doi: 10.1177/014107688507800910.
Akathisia, an Easily Overlooked Side Effect.
Onishi H, Yoshioka A, Sato I, Uchida N, Ishida M.
J Clin Oncol. 2023 Sep 1;41(25):4184-4185. doi: 10.1200/JCO.23.00853. Epub 2023 Jun 23.
The clinical challenges of akathisia.
Lohr JB, Eidt CA, Abdulrazzaq Alfaraj A, Soliman MA.
CNS Spectr. 2015 Dec;20 Suppl 1:1-14; quiz 15-6. doi: 10.1017/S1092852915000838.
Selective serotonin reuptake inhibitor-induced akathisia.
Koliscak LP, Makela EH.
J Am Pharm Assoc (2003). 2009 Mar-Apr;49(2):e28-36; quiz e37-8. doi: 10.1331/JAPhA.2009.08083.
